What is ALLR's earnings growth forecast for 2025-2025?
(NASDAQ: ALLR) Allarity Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Allarity Therapeutics's earnings in 2025 is -$25,154,000.
In 2025, ALLR is forecast to generate -$797,140,428 in earnings, with the lowest earnings forecast at -$797,140,428 and the highest earnings forecast at -$797,140,428.
What is ALLR's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: ALLR) forecast ROE is -6,749.14%, which is considered weak.
What is ALLR's Earnings Per Share (EPS) forecast for 2025-2025?
(NASDAQ: ALLR) Allarity Therapeutics's current Earnings Per Share (EPS) is -$15.65. In 2025, ALLR's EPS is forecast to hit -$46.85 (min: -$46.85, max: -$46.85).
What is ALLR's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: ALLR) forecast ROA is -3,519.38%, which is lower than the forecast US Biotechnology industry average of 84.94%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.